Index RUT P/E - EPS (ttm) -3.11 Insider Own 12.77% Shs Outstand 50.37M Perf Week 0.00%
Market Cap 431.10M Forward P/E 18.90 EPS next Y 0.45 Insider Trans 0.43% Shs Float 44.04M Perf Month 1.30%
Income -156.20M PEG - EPS next Q 0.06 Inst Own 90.10% Short Float 2.91% Perf Quarter 10.48%
Sales 1.03B P/S 0.42 EPS this Y 74.54% Inst Trans 1.98% Short Ratio 4.18 Perf Half Y 7.83%
Book/sh 10.39 P/B 0.82 EPS next Y 23.25% ROA -11.49% Short Interest 1.28M Perf Year -17.41%
Cash/sh 0.60 P/C 14.23 EPS next 5Y 31.64% ROE -26.18% 52W Range 6.85 - 11.74 Perf YTD 9.35%
Dividend Est. - P/FCF 9.09 EPS past 5Y - ROI -14.77% 52W High -27.26% Beta 1.22
Dividend TTM - Quick Ratio 1.53 Sales past 5Y -1.05% Gross Margin 45.66% 52W Low 24.67% ATR (14) 0.41
Dividend Ex-Date - Current Ratio 1.53 EPS Y/Y TTM -92.56% Oper. Margin 4.50% RSI (14) 53.74 Volatility 8.30% 4.56%
Employees 10700 Debt/Eq 1.09 Sales Y/Y TTM -1.10% Profit Margin -15.09% Recom 2.67 Target Price 9.20
Option/Short Yes / Yes LT Debt/Eq 1.02 EPS Q/Q -615.86% Payout - Rel Volume 1.14 Prev Close 8.45
Sales Surprise -0.35% EPS Surprise -26.20% Sales Q/Q -0.92% Earnings Mar 05 AMC Avg Volume 306.15K Price 8.54
SMA20 1.39% SMA50 3.93% SMA200 3.19% Trades
Volume 347,216 Change 1.07%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-09-24 Upgrade Jefferies
Hold → Buy
$8.25 → $9.50
May-14-24 Upgrade Leerink Partners
Underperform → Market Perform
$8.50
May-09-24 Downgrade Jefferies
Buy → Hold
$14 → $8.75
Mar-07-24 Upgrade UBS
Sell → Neutral
$9.50
Dec-12-23 Initiated TD Cowen
Market Perform
$12
Jun-20-23 Initiated SVB Securities
Underperform
$10
Mar-16-23 Initiated Goldman
Neutral
$15
Dec-13-22 Initiated CJS Securities
Market Perform
$18
Dec-08-22 Initiated UBS
Sell
$12
Dec-06-22 Initiated Stifel
Buy
$17
Oct-14-22 Initiated Oppenheimer
Perform
Aug-30-22 Initiated Jefferies
Buy
$20
Aug-25-22 Initiated Credit Suisse
Neutral
$19
Aug-18-22 Initiated Citigroup
Neutral
$17
Show Previous Ratings
Mar-11-25 04:15PM
Mar-07-25 02:12AM
Mar-06-25 11:54PM
(Thomson Reuters StreetEvents) -6.09%
Mar-05-25 05:30PM
04:44PM
(Associated Press Finance)
04:16PM
Loading…
04:16PM
07:19AM
Mar-04-25 07:16AM
Feb-25-25 04:15PM
Feb-21-25 08:50AM
Feb-13-25 04:15PM
Jan-30-25 05:05PM
Jan-29-25 08:50AM
Dec-19-24 08:44AM
Dec-04-24 08:30AM
04:17PM
Loading…
Nov-19-24 04:17PM
Nov-08-24 08:24AM
02:22AM
02:06AM
(Thomson Reuters StreetEvents)
Nov-07-24 07:30AM
Nov-06-24 06:30PM
05:26PM
(Associated Press Finance)
04:19PM
07:37AM
Nov-05-24 08:00AM
Oct-17-24 04:35PM
Oct-08-24 04:10PM
Oct-04-24 05:04PM
Sep-20-24 08:40AM
Sep-06-24 06:43PM
04:10PM
Loading…
Aug-21-24 04:10PM
Aug-06-24 05:35PM
04:40PM
04:32PM
(Associated Press Finance)
04:10PM
Aug-05-24 08:50AM
Aug-01-24 12:00PM
Jul-30-24 10:01AM
Jul-29-24 09:00AM
Jul-25-24 11:00AM
Jul-24-24 12:10PM
Jul-22-24 09:00AM
07:45AM
Jul-18-24 09:55AM
08:57AM
Jul-15-24 07:45AM
Jul-12-24 09:00AM
06:00AM
Jul-09-24 04:10PM
Jul-08-24 07:45AM
Jul-05-24 09:20AM
Jul-01-24 04:15PM
Jun-27-24 04:15PM
Jun-24-24 07:45AM
Jun-17-24 09:00AM
Jun-12-24 04:10PM
Jun-10-24 07:45AM
May-29-24 09:00AM
May-23-24 04:30PM
May-21-24 04:10PM
May-20-24 04:10PM
May-14-24 07:54AM
May-10-24 03:01PM
11:24AM
May-09-24 01:47PM
Hedge Fund and Insider Trading News: John Paulson, Ken Griffin, Marshall Wace LLP, Bridgewater Associates, AREX Capital Management, Ancora Advisors, Millennium Management, Balyasny Asset Management, Caesars Entertainment Inc (CZR), Vestis Corporation (VSTS), and More
(Insider Monkey) -14.54%
09:15AM
07:13AM
May-08-24 06:55PM
05:48PM
(Associated Press Finance)
04:15PM
04:10PM
Apr-10-24 04:10PM
Mar-20-24 05:45PM
Mar-10-24 08:38AM
Mar-07-24 01:39PM
Mar-06-24 09:52PM
04:51PM
(Associated Press Finance)
04:15PM
Feb-08-24 04:10PM
Dec-17-23 05:05AM
Nov-12-23 08:57AM
Nov-09-23 01:24AM
(Thomson Reuters StreetEvents)
Nov-07-23 07:15PM
06:10PM
(Associated Press Finance)
04:11PM
Nov-02-23 10:00AM
Oct-31-23 10:01AM
Oct-25-23 06:30PM
Oct-05-23 10:00AM
Oct-04-23 04:41PM
Oct-03-23 05:47PM
Aug-23-23 04:51PM
Aug-14-23 09:00AM
Aug-12-23 09:27AM
Aug-11-23 12:12AM
(Thomson Reuters StreetEvents)
Aug-09-23 06:40PM
05:36PM
04:30PM
Aug-08-23 07:50AM
Jul-27-23 11:00AM
Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
McQuiddy Collin Chief Accounting Officer Mar 10 '25 Sale 8.58 1,096 9,404 0 Mar 10 08:32 PM Bolton Jeffrey Director Dec 12 '24 Buy 8.69 4,000 34,760 98,144 Dec 12 05:01 PM MCGUIGAN STUART M Director Dec 10 '24 Buy 8.81 15,000 132,150 46,810 Dec 11 05:56 PM Bolton Jeffrey Director Nov 08 '24 Buy 7.77 7,000 54,377 91,144 Nov 12 05:14 PM Bolton Jeffrey Director Nov 12 '24 Buy 7.60 3,000 22,800 94,144 Nov 12 05:14 PM Bolton Jeffrey Director Aug 22 '24 Buy 8.01 5,000 40,050 78,877 Aug 23 04:43 PM Bolton Jeffrey Director Aug 09 '24 Buy 8.29 5,000 41,450 73,877 Aug 12 04:04 PM Bolton Jeffrey Director Aug 08 '24 Buy 8.60 2,000 17,200 68,877 Aug 12 04:04 PM Bolton Jeffrey Director May 17 '24 Buy 8.33 10,000 83,300 52,299 May 17 05:57 PM Hoeflinger Erin Director May 14 '24 Buy 9.00 2,000 18,000 30,399 May 15 06:29 PM Bolton Jeffrey Director May 10 '24 Buy 8.24 10,000 82,400 42,299 May 10 05:27 PM
Index - P/E 29.60 EPS (ttm) 19.91 Insider Own 1.86% Shs Outstand 14.56M Perf Week -1.00%
Market Cap 8.62B Forward P/E 21.76 EPS next Y 27.08 Insider Trans -3.31% Shs Float 14.36M Perf Month 6.43%
Income 302.00M PEG 3.95 EPS next Q 5.51 Inst Own 96.09% Short Float 2.07% Perf Quarter 6.63%
Sales 2.43B P/S 3.55 EPS this Y 6.46% Inst Trans -1.73% Short Ratio 2.84 Perf Half Y 3.11%
Book/sh 76.87 P/B 7.67 EPS next Y 9.99% ROA 17.12% Short Interest 0.30M Perf Year -7.97%
Cash/sh 12.19 P/C 48.36 EPS next 5Y 7.49% ROE 27.12% 52W Range 512.12 - 654.62 Perf YTD 11.22%
Dividend Est. 2.05 (0.35%) P/FCF 23.44 EPS past 5Y 8.37% ROI 24.80% 52W High -9.99% Beta 0.51
Dividend TTM 1.90 (0.32%) Quick Ratio 1.35 Sales past 5Y 4.68% Gross Margin 32.55% 52W Low 15.06% ATR (14) 13.58
Dividend Ex-Date Feb 24, 2025 Current Ratio 1.38 EPS Y/Y TTM 11.17% Oper. Margin 15.08% RSI (14) 59.57 Volatility 2.15% 2.28%
Employees 15695 Debt/Eq 0.13 Sales Y/Y TTM 7.37% Profit Margin 12.42% Recom 1.25 Target Price 663.67
Option/Short Yes / Yes LT Debt/Eq 0.09 EPS Q/Q 2.16% Payout 9.05% Rel Volume 0.97 Prev Close 598.50
Sales Surprise 0.61% EPS Surprise 0.69% Sales Q/Q 9.23% Earnings Feb 26 AMC Avg Volume 104.44K Price 589.24
SMA20 2.97% SMA50 5.89% SMA200 5.04% Trades
Volume 105,449 Change -1.55%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-20 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$448 → $535
Nov-01-19 Upgrade JMP Securities
Mkt Perform → Mkt Outperform
$490
Sep-06-19 Reiterated BofA/Merrill
Buy
$470 → $500
Oct-12-18 Initiated BofA/Merrill
Buy
$390
Aug-28-17 Initiated KeyBanc Capital Mkts
Sector Weight
Nov-01-16 Reiterated RBC Capital Mkts
Sector Perform
$162 → $148
Jul-27-16 Reiterated RBC Capital Mkts
Sector Perform
$136 → $162
May-02-16 Reiterated RBC Capital Mkts
Sector Perform
$135 → $136
Oct-26-15 Reiterated RBC Capital Mkts
Sector Perform
$129 → $154
Oct-26-15 Reiterated Oppenheimer
Outperform
$150 → $152
Sep-22-15 Reiterated Oppenheimer
Outperform
$147 → $150
Jul-27-15 Reiterated RBC Capital Mkts
Sector Perform
$110 → $129
Feb-19-15 Reiterated Oppenheimer
Outperform
$122 → $123
Sep-23-14 Reiterated Oppenheimer
Outperform
$110 → $115
Jun-10-14 Reiterated RBC Capital Mkts
Sector Perform
$70 → $74
May-01-14 Reiterated Oppenheimer
Outperform
$90 → $92
Sep-10-13 Reiterated Deutsche Bank
Hold
$70 → $63
Mar-04-11 Reiterated Barclays Capital
Underweight
$65 → $9
Feb-17-11 Reiterated RBC Capital Mkts
Sector Perform
$53 → $67
Feb-17-11 Reiterated Oppenheimer
Outperform
$67 → $72
Show Previous Ratings
Mar-12-25 05:02AM
Mar-03-25 01:24PM
Feb-28-25 02:22AM
12:28AM
(Thomson Reuters StreetEvents)
Feb-26-25 06:15PM
05:15PM
Loading…
05:15PM
(Associated Press Finance)
05:00PM
04:15PM
Feb-25-25 08:06AM
Feb-14-25 01:30PM
04:03AM
04:03AM
04:01AM
Feb-13-25 01:13PM
04:01AM
05:35PM
Loading…
Feb-11-25 05:35PM
04:03AM
04:02AM
Jan-07-25 12:00PM
Dec-03-24 12:00PM
Nov-28-24 08:28AM
Nov-08-24 11:43AM
Nov-05-24 12:00PM
Oct-31-24 03:10AM
01:54AM
(Thomson Reuters StreetEvents)
Oct-29-24 05:55PM
04:52PM
(Associated Press Finance)
04:15PM
Oct-01-24 01:37PM
Sep-18-24 09:45AM
01:46PM
Loading…
Sep-13-24 01:46PM
Sep-11-24 09:44AM
Sep-10-24 03:00PM
Aug-23-24 11:30AM
Aug-15-24 09:45AM
Aug-09-24 05:00PM
05:00PM
Aug-08-24 11:17AM
Aug-07-24 01:45PM
Aug-02-24 11:54AM
Jul-31-24 01:00PM
Jul-30-24 09:45AM
Jul-29-24 12:45PM
Jul-26-24 03:11AM
(Thomson Reuters StreetEvents)
Jul-25-24 08:49AM
Jul-24-24 06:05PM
05:04PM
(Associated Press Finance)
04:15PM
Jul-16-24 09:10AM
Jul-01-24 12:00PM
Jun-13-24 07:01PM
Jun-08-24 02:58AM
May-29-24 12:00PM
May-24-24 11:31AM
May-20-24 02:49PM
May-17-24 03:00PM
11:15AM
May-07-24 12:00PM
Apr-30-24 12:15PM
Apr-26-24 12:35PM
03:17AM
Apr-25-24 11:37PM
(Thomson Reuters StreetEvents) -7.22%
08:27AM
Apr-24-24 06:10PM
05:35PM
05:14PM
05:05PM
(Associated Press Finance)
04:15PM
Apr-17-24 10:26AM
10:00AM
Apr-03-24 04:29AM
Apr-01-24 03:00PM
12:00PM
Mar-28-24 11:30AM
Mar-22-24 03:00PM
Mar-18-24 09:45AM
Mar-14-24 09:00AM
Mar-13-24 09:00AM
Mar-08-24 12:00PM
Mar-04-24 12:45PM
Feb-29-24 09:03AM
06:37AM
12:15AM
(Thomson Reuters StreetEvents)
Feb-27-24 08:00PM
07:15PM
06:20PM
(Associated Press Finance)
04:53PM
04:15PM
Feb-16-24 12:27PM
Feb-14-24 12:00PM
Feb-05-24 10:59AM
Jan-22-24 08:29AM
Jan-08-24 11:24AM
Dec-29-23 12:00PM
Dec-25-23 07:14AM
Dec-22-23 04:18PM
Dec-18-23 01:20PM
Dec-14-23 09:05PM
Nov-30-23 03:00PM
Nov-28-23 05:04AM
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Witzeman Michael D VP & Chief Financial Officer Mar 10 '25 Option Exercise 445.35 8,796 3,917,299 13,154 Mar 11 03:12 PM MCNAMARA KEVIN J president and CEO Mar 06 '25 Sale 593.67 2,000 1,187,340 102,679 Mar 07 11:03 AM MCNAMARA KEVIN J Director Mar 06 '25 Proposed Sale 593.60 2,000 1,187,199 Mar 06 04:28 PM LEE SPENCER S executive vice president Mar 03 '25 Sale 592.25 1,326 785,324 17,627 Mar 03 03:28 PM LEE SPENCER S executive vice president Feb 14 '25 Option Exercise 553.39 1,073 593,787 19,295 Feb 18 05:22 PM Westfall Nicholas Michael Executive Vice President Feb 14 '25 Option Exercise 553.39 1,473 815,143 7,582 Feb 18 05:05 PM Witzeman Michael D VP & Chief Financial Officer Feb 14 '25 Option Exercise 553.39 850 470,382 4,634 Feb 18 04:49 PM HUTTON THOMAS C vice president Feb 14 '25 Option Exercise 553.39 411 227,443 33,176 Feb 18 04:03 PM MCNAMARA KEVIN J president and CEO Feb 14 '25 Option Exercise 553.39 5,321 2,944,588 107,056 Feb 18 03:41 PM Judkins Brian C VP and Chief Legal Officer Feb 14 '25 Option Exercise 553.39 724 400,654 2,402 Feb 18 03:14 PM Judkins Brian C VP and Chief Legal Officer Dec 30 '24 Buy 519.50 145 75,328 1,678 Dec 30 11:10 AM LEE SPENCER S executive vice president Nov 27 '24 Sale 575.62 732 421,356 18,287 Nov 29 10:38 AM MCNAMARA KEVIN J president and CEO Nov 25 '24 Sale 572.77 2,000 1,145,540 101,735 Nov 26 11:24 AM MCNAMARA KEVIN J Officer Nov 25 '24 Proposed Sale 571.11 2,000 1,142,220 Nov 25 03:44 PM LEE SPENCER S executive vice president Nov 22 '24 Sale 565.71 1,000 565,710 19,019 Nov 22 01:37 PM MCNAMARA KEVIN J president and CEO Sep 26 '24 Sale 598.81 2,000 1,197,620 103,735 Sep 27 11:27 AM WALSH GEORGE J III Director Sep 26 '24 Sale 597.47 400 238,988 3,046 Sep 27 11:17 AM MCNAMARA KEVIN J Director Sep 26 '24 Proposed Sale 598.75 2,000 1,197,505 Sep 26 04:22 PM Westfall Nicholas Michael Executive Vice President Sep 09 '24 Sale 569.35 1,713 975,297 6,109 Sep 10 11:14 AM Westfall Nicholas Michael Executive Vice President Sep 04 '24 Option Exercise 471.74 15,333 7,233,189 21,442 Sep 06 10:20 AM LINDELL ANDREA R Director Aug 16 '24 Sale 571.51 831 474,925 5,725 Aug 26 12:21 PM WALSH GEORGE J III Director Aug 21 '24 Sale 577.95 200 115,590 3,446 Aug 22 12:06 PM LEE SPENCER S executive vice president Aug 09 '24 Option Exercise 413.19 9,000 3,718,710 27,611 Aug 09 02:13 PM LEE SPENCER S executive vice president Aug 08 '24 Sale 580.48 1,016 589,768 18,611 Aug 09 02:13 PM HUTTON THOMAS C vice president Aug 06 '24 Sale 576.32 4,827 2,781,897 32,765 Aug 09 01:56 PM MCNAMARA KEVIN J Director Aug 05 '24 Proposed Sale 569.57 2,000 1,139,142 Aug 06 11:17 AM MCNAMARA KEVIN J president and CEO Aug 05 '24 Option Exercise 445.35 5,000 2,226,750 112,049 Aug 06 11:14 AM MCNAMARA KEVIN J president and CEO Aug 05 '24 Sale 569.63 2,000 1,139,260 105,735 Aug 06 11:14 AM HUTTON THOMAS C Director Aug 01 '24 Proposed Sale 554.39 4,827 2,676,041 Aug 01 04:07 PM Witzeman Michael D VP & Chief Financial Officer Jul 31 '24 Option Exercise 471.74 7,948 3,749,390 11,009 Aug 01 03:42 PM Westfall Nicholas Michael Executive Vice President Jul 30 '24 Sale 561.58 2,000 1,123,160 5,990 Jul 31 10:49 AM Nicholas M. Westfall Officer Jul 30 '24 Proposed Sale 550.29 23,000 12,656,670 Jul 30 11:36 AM GRACE PATRICK P Director Jun 12 '24 Sale 540.98 284 153,638 3,270 Jun 13 03:45 PM MCNAMARA KEVIN J president and CEO Jun 06 '24 Sale 544.17 1,500 816,255 107,049 Jun 07 03:11 PM MCNAMARA KEVIN J president and CEO May 16 '24 Sale 567.54 4,000 2,270,160 108,549 May 17 11:05 AM Witzeman Michael D VP & Chief Financial Officer May 07 '24 Option Exercise 413.19 1,100 454,509 3,982 May 09 01:34 PM LEE SPENCER S executive vice president Mar 28 '24 Option Exercise 106.59 13,000 1,385,670 33,760 Apr 01 11:43 AM LEE SPENCER S executive vice president Mar 28 '24 Sale 641.65 2,000 1,283,300 20,760 Apr 01 11:43 AM Witzeman Michael D VP & Chief Financial Officer Mar 20 '24 Option Exercise 413.19 2,600 1,074,294 5,887 Mar 22 01:21 PM Witzeman Michael D VP & Chief Financial Officer Mar 21 '24 Sale 643.14 2,650 1,704,321 2,882 Mar 22 01:21 PM Judkins Brian C VP and Chief Legal Officer Mar 20 '24 Option Exercise 443.22 11,958 5,300,013 12,580 Mar 22 11:26 AM Judkins Brian C VP and Chief Legal Officer Mar 20 '24 Sale 645.00 11,158 7,196,910 1,422 Mar 22 11:26 AM
Index - P/E 70.75 EPS (ttm) 1.30 Insider Own 2.59% Shs Outstand 32.78M Perf Week 0.10%
Market Cap 3.02B Forward P/E 17.36 EPS next Y 5.31 Insider Trans -0.24% Shs Float 31.96M Perf Month 0.10%
Income 43.23M PEG 11.47 EPS next Q 1.12 Inst Own 89.01% Short Float 9.04% Perf Quarter 7.08%
Sales 2.35B P/S 1.29 EPS this Y 11.76% Inst Trans 1.36% Short Ratio 7.20 Perf Half Y -5.56%
Book/sh 34.61 P/B 2.66 EPS next Y 9.89% ROA 2.06% Short Interest 2.89M Perf Year -1.07%
Cash/sh 9.30 P/C 9.91 EPS next 5Y 6.17% ROE 3.93% 52W Range 82.15 - 98.95 Perf YTD 1.46%
Dividend Est. - P/FCF 14.05 EPS past 5Y -19.40% ROI 2.83% 52W High -6.90% Beta 0.90
Dividend TTM - Quick Ratio 1.23 Sales past 5Y 3.76% Gross Margin 25.87% 52W Low 12.14% ATR (14) 0.93
Dividend Ex-Date - Current Ratio 1.23 EPS Y/Y TTM 539.66% Oper. Margin 8.92% RSI (14) 53.19 Volatility 0.89% 1.02%
Employees 19000 Debt/Eq 0.40 Sales Y/Y TTM 5.01% Profit Margin 1.84% Recom 2.80 Target Price 100.86
Option/Short Yes / Yes LT Debt/Eq 0.35 EPS Q/Q -206.00% Payout 0.00% Rel Volume 1.12 Prev Close 92.09
Sales Surprise -0.08% EPS Surprise -8.35% Sales Q/Q 4.78% Earnings Feb 26 AMC Avg Volume 401.63K Price 92.12
SMA20 0.13% SMA50 0.16% SMA200 -1.82% Trades
Volume 446,688 Change 0.03%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-29-24 Downgrade Deutsche Bank
Buy → Hold
$101
Jul-01-24 Downgrade William Blair
Outperform → Mkt Perform
Jun-07-23 Downgrade Truist
Buy → Hold
$97
Apr-21-23 Initiated Cantor Fitzgerald
Neutral
$87
Mar-13-23 Initiated Barclays
Equal Weight
$93
Oct-27-22 Downgrade Raymond James
Outperform → Mkt Perform
Aug-02-22 Downgrade UBS
Neutral → Sell
$145 → $95
Jun-29-22 Initiated Stifel
Hold
$128
Jun-21-22 Downgrade BofA Securities
Neutral → Underperform
$145 → $102
Mar-01-22 Upgrade UBS
Sell → Neutral
$168
Feb-25-22 Upgrade BMO Capital Markets
Market Perform → Outperform
$210 → $190
Feb-25-22 Reiterated Truist
Buy
$210 → $200
Feb-25-22 Reiterated RBC Capital Mkts
Outperform
$221 → $199
Feb-25-22 Reiterated Raymond James
Outperform
$225 → $200
Feb-25-22 Reiterated Oppenheimer
Outperform
$225 → $200
Feb-25-22 Reiterated Credit Suisse
Outperform
$200 → $195
Sep-27-21 Initiated SVB Leerink
Mkt Perform
$170
Sep-24-21 Initiated UBS
Sell
$150
Sep-10-21 Initiated Cowen
Market Perform
$195
Aug-10-21 Reiterated The Benchmark Company
Buy
$320 → $235
Show Previous Ratings
Feb-26-25 09:00PM
05:50PM
04:55PM
(Associated Press Finance)
04:30PM
Feb-21-25 05:12PM
(The Wall Street Journal)
04:37PM
Loading…
04:37PM
Feb-12-25 10:00AM
Feb-03-25 06:30AM
Jan-08-25 06:18PM
(The Wall Street Journal)
Jan-07-25 04:37AM
Dec-28-24 06:40AM
Dec-27-24 01:30PM
12:58PM
11:28AM
11:11AM
10:41AM
Loading…
10:41AM
09:40AM
08:09AM
07:54AM
06:24AM
Dec-24-24 08:32AM
Dec-06-24 11:31AM
Dec-04-24 05:56PM
Nov-14-24 03:27PM
Nov-12-24 03:19PM
(The Wall Street Journal)
02:42PM
(Associated Press Finance)
02:34PM
12:02PM
09:14AM
Nov-06-24 09:30PM
07:10PM
Loading…
07:10PM
06:09PM
(Associated Press Finance)
04:30PM
Oct-16-24 12:10PM
Sep-30-24 12:00PM
Sep-25-24 07:30AM
Aug-21-24 06:30AM
Jul-26-24 07:53AM
Jul-25-24 09:30AM
Jul-24-24 09:53PM
05:45PM
04:39PM
(Associated Press Finance)
04:30PM
Jul-15-24 09:50AM
Jul-09-24 10:00AM
Jul-02-24 04:41AM
Jul-01-24 12:16PM
(Associated Press) +5.32%
May-29-24 09:50AM
09:00AM
May-28-24 09:40AM
May-24-24 11:31AM
Apr-29-24 08:19AM
Apr-24-24 10:53PM
09:00PM
06:00PM
04:57PM
(Associated Press Finance)
04:45PM
10:01AM
Apr-23-24 09:40AM
Mar-25-24 09:40AM
Mar-22-24 11:30AM
Mar-20-24 08:56AM
Mar-19-24 06:16PM
06:02PM
05:41PM
Feb-23-24 11:31AM
Feb-21-24 08:00PM
06:00PM
05:04PM
(Associated Press Finance)
04:57PM
04:30PM
Feb-14-24 10:00AM
Feb-08-24 07:30AM
Nov-29-23 08:31PM
Nov-23-23 11:30AM
Nov-22-23 01:44PM
Oct-26-23 08:19AM
Oct-25-23 10:27PM
(Thomson Reuters StreetEvents)
Oct-24-23 07:30PM
06:02PM
05:50PM
04:40PM
(Associated Press Finance)
04:30PM
Oct-18-23 04:30PM
09:40AM
Oct-03-23 04:58PM
Oct-02-23 09:40AM
Aug-31-23 11:31AM
07:30AM
Jul-28-23 11:47AM
Jul-27-23 08:47AM
Jul-26-23 10:00PM
06:05PM
05:00PM
04:30PM
Jul-24-23 10:00AM
Jul-19-23 10:01AM
Jul-06-23 10:06AM
Jun-28-23 09:21AM
Jun-27-23 12:45PM
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Guidroz Allyson Chief Accounting Officer Mar 04 '25 Sale 92.03 2,041 187,833 8,761 Mar 06 04:02 PM Guidroz Allyson Officer Mar 04 '25 Proposed Sale 91.97 2,041 187,714 Mar 04 05:50 PM North Michael Paul Former Officer Nov 07 '24 Proposed Sale 96.80 11,221 1,086,220 Nov 07 04:13 PM
Index RUT P/E 21.98 EPS (ttm) 4.23 Insider Own 2.09% Shs Outstand 18.15M Perf Week -3.22%
Market Cap 1.69B Forward P/E 13.96 EPS next Y 6.67 Insider Trans -17.68% Shs Float 17.79M Perf Month -20.07%
Income 73.60M PEG 1.80 EPS next Q 1.34 Inst Own 100.61% Short Float 3.45% Perf Quarter -22.90%
Sales 1.15B P/S 1.47 EPS this Y 15.19% Inst Trans 2.92% Short Ratio 3.04 Perf Half Y -26.61%
Book/sh 53.48 P/B 1.74 EPS next Y 10.06% ROA 5.91% Short Interest 0.61M Perf Year -8.96%
Cash/sh 5.44 P/C 17.10 EPS next 5Y 12.18% ROE 8.78% 52W Range 87.88 - 136.72 Perf YTD -25.74%
Dividend Est. - P/FCF 15.33 EPS past 5Y 19.04% ROI 5.98% 52W High -31.91% Beta 0.96
Dividend TTM - Quick Ratio 1.67 Sales past 5Y 12.26% Gross Margin 31.31% 52W Low 5.93% ATR (14) 3.69
Dividend Ex-Date - Current Ratio 1.67 EPS Y/Y TTM 10.68% Oper. Margin 10.02% RSI (14) 23.53 Volatility 3.69% 3.59%
Employees 49703 Debt/Eq 0.28 Sales Y/Y TTM 9.06% Profit Margin 6.37% Recom 1.42 Target Price 136.27
Option/Short Yes / Yes LT Debt/Eq 0.27 EPS Q/Q -11.10% Payout 0.00% Rel Volume 1.19 Prev Close 94.71
Sales Surprise 0.77% EPS Surprise 1.42% Sales Q/Q 7.52% Earnings Feb 24 AMC Avg Volume 202.00K Price 93.09
SMA20 -8.99% SMA50 -20.28% SMA200 -24.06% Trades
Volume 237,977 Change -1.71%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-16-24 Initiated JMP Securities
Mkt Outperform
$150
Oct-11-24 Initiated KeyBanc Capital Markets
Overweight
$150
Jun-28-24 Initiated Macquarie
Outperform
$136
Apr-23-24 Downgrade Barclays
Equal Weight → Underweight
$83
Mar-06-24 Initiated Barclays
Equal Weight
$88
Feb-05-24 Resumed William Blair
Outperform
Dec-12-23 Initiated TD Cowen
Outperform
$105
Jun-29-22 Initiated Stifel
Buy
$101
Apr-13-22 Initiated BofA Securities
Buy
$110
Oct-22-19 Resumed Stephens
Overweight
Jun-27-19 Initiated BMO Capital Markets
Market Perform
Feb-04-19 Upgrade Robert W. Baird
Neutral → Outperform
Oct-08-18 Initiated RBC Capital Mkts
Outperform
$81
Aug-21-18 Initiated Jefferies
Buy
$75
Aug-20-18 Initiated Raymond James
Outperform
$75
Sep-30-14 Upgrade Oppenheimer
Perform → Outperform
$24
Jul-16-13 Downgrade Robert W. Baird
Outperform → Neutral
$14 → $20
Apr-04-13 Downgrade Oppenheimer
Outperform → Perform
$12 → $13
Dec-07-09 Initiated Robert W. Baird
Outperform
$13
Dec-07-09 Initiated Oppenheimer
Outperform
$12
Show Previous Ratings
Mar-11-25 04:05PM
11:00AM
08:06AM
Feb-26-25 03:08AM
(Thomson Reuters StreetEvents)
02:08AM
11:00AM
Loading…
Feb-25-25 11:00AM
01:29AM
Feb-24-25 06:30PM
05:35PM
04:48PM
(Associated Press Finance)
04:16PM
04:05PM
09:35AM
Feb-23-25 08:00AM
Feb-22-25 04:16PM
12:45PM
Loading…
Feb-20-25 12:45PM
09:40AM
Feb-19-25 09:15AM
Feb-14-25 04:03AM
Feb-11-25 04:02AM
Feb-10-25 11:00AM
Jan-28-25 09:40AM
Dec-20-24 03:30PM
(Investor's Business Daily)
Dec-16-24 01:52PM
Dec-06-24 09:54AM
Dec-05-24 12:00PM
Dec-02-24 04:05PM
Nov-12-24 11:00AM
Nov-06-24 02:40AM
(Thomson Reuters StreetEvents) +5.47%
02:15AM
06:30PM
Loading…
Nov-04-24 06:30PM
06:00PM
05:00PM
(Associated Press Finance)
04:05PM
07:05AM
Nov-01-24 09:04AM
Oct-28-24 10:01AM
Oct-21-24 11:00AM
Oct-07-24 12:00PM
Sep-17-24 09:30AM
Sep-16-24 08:29AM
Sep-13-24 07:00PM
07:00PM
Sep-12-24 01:04AM
Sep-03-24 07:01PM
Aug-28-24 07:00PM
Aug-05-24 09:54PM
06:30PM
05:35PM
04:32PM
(Associated Press Finance)
04:05PM
Jul-22-24 11:00AM
10:01AM
Jun-28-24 04:01PM
Jun-26-24 08:45PM
04:01PM
Jun-17-24 02:47PM
Jun-10-24 08:00AM
May-29-24 11:00AM
09:00AM
May-21-24 08:00AM
May-09-24 09:15AM
May-08-24 04:04PM
03:24AM
May-07-24 11:00AM
09:19AM
06:11AM
May-06-24 06:33PM
06:30PM
06:05PM
05:03PM
(Associated Press Finance)
04:05PM
May-02-24 09:40AM
Apr-23-24 09:18AM
08:00AM
Apr-22-24 11:00AM
Apr-13-24 12:18PM
Apr-09-24 09:00AM
Mar-05-24 11:00AM
Mar-04-24 09:15AM
Mar-01-24 08:30AM
Feb-29-24 12:00PM
Feb-27-24 11:00AM
Feb-26-24 06:30PM
04:54PM
(Associated Press Finance)
04:53PM
04:05PM
Feb-21-24 09:15AM
Feb-12-24 11:00AM
Nov-22-23 09:55AM
Nov-17-23 05:05AM
Nov-06-23 09:55AM
Nov-01-23 12:37PM
11:00AM
Oct-30-23 05:50PM
05:43PM
04:50PM
(Associated Press Finance)
04:05PM
Oct-23-23 10:15AM
Oct-19-23 11:40AM
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
RAINES MONICA EVP/CCO and Quality Officer Mar 03 '25 Sale 96.23 237 22,807 14,645 Mar 04 04:00 PM Stevenson Roberton James EVP & Chief HR Officer Feb 25 '25 Sale 99.90 308 30,769 12,812 Feb 27 04:00 PM GAFFNEY SEAN EVP / Chief Legal Officer Feb 25 '25 Sale 99.84 479 47,823 18,179 Feb 27 04:00 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Feb 25 '25 Sale 99.71 343 34,201 9,841 Feb 27 04:00 PM BICKHAM W BRADLEY President and COO Feb 25 '25 Sale 99.74 2,444 243,765 51,505 Feb 27 04:00 PM POFF BRIAN EVP/Chief Financial Officer Feb 25 '25 Sale 99.88 2,304 230,124 32,969 Feb 27 04:00 PM Anderson Darby EVP/Chief Legislative Officer Feb 25 '25 Sale 99.88 418 41,750 44,144 Feb 27 04:00 PM RAINES MONICA EVP/CCO and Quality Officer Feb 25 '25 Sale 99.73 254 25,331 14,882 Feb 27 04:00 PM BLESSING CLIFF DONALD EVP/Chief Development Officer Feb 25 '25 Sale 99.81 191 19,064 10,579 Feb 27 04:00 PM TUCKER DAVID W. EVP / Chief Strategy Officer Feb 25 '25 Sale 99.77 411 41,005 11,138 Feb 27 04:00 PM ALLISON R DIRK CEO and Chairman Feb 25 '25 Sale 99.98 2,564 256,349 102,961 Feb 27 04:00 PM POFF BRIAN EVP/Chief Financial Officer Feb 24 '25 Sale 108.18 3,164 342,282 35,273 Feb 25 04:00 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Feb 24 '25 Sale 108.18 1,151 124,515 10,184 Feb 25 04:00 PM Stevenson Roberton James EVP & Chief HR Officer Feb 24 '25 Sale 108.18 873 94,441 13,120 Feb 25 04:00 PM RAINES MONICA EVP/CCO and Quality Officer Feb 24 '25 Sale 108.18 626 67,721 15,136 Feb 25 04:00 PM Anderson Darby EVP/Chief Legislative Officer Feb 24 '25 Sale 108.18 1,342 145,178 44,562 Feb 25 04:00 PM BICKHAM W BRADLEY President and COO Feb 24 '25 Sale 108.18 3,470 375,385 53,949 Feb 25 04:00 PM GAFFNEY SEAN EVP / Chief Legal Officer Feb 24 '25 Sale 108.18 1,532 165,732 18,658 Feb 25 04:00 PM BLESSING CLIFF DONALD EVP/Chief Development Officer Feb 24 '25 Sale 108.18 385 41,649 10,770 Feb 25 04:00 PM TUCKER DAVID W. EVP / Chief Strategy Officer Feb 24 '25 Sale 108.18 1,328 143,663 11,549 Feb 25 04:00 PM ALLISON R DIRK CEO and Chairman Feb 24 '25 Sale 108.18 8,203 887,401 105,525 Feb 25 04:00 PM ALLISON R DIRK CEO and Chairman Jan 02 '25 Option Exercise 19.71 25,000 492,750 104,397 Jan 03 05:30 PM ALLISON R DIRK CEO and Chairman Jan 02 '25 Sale 124.76 25,000 3,118,877 79,397 Jan 03 05:30 PM DIRK ALLISON Officer Jan 02 '25 Proposed Sale 124.76 25,000 3,118,885 Jan 02 04:17 PM Stevenson Roberton James EVP & Chief HR Officer Dec 09 '24 Option Exercise 90.87 2,250 204,458 12,467 Dec 10 05:30 PM Stevenson Roberton James EVP & Chief HR Officer Dec 09 '24 Sale 121.00 2,250 272,250 10,217 Dec 10 05:30 PM ALLISON R DIRK CEO and Chairman Nov 25 '24 Option Exercise 19.71 75,000 1,478,250 154,397 Nov 26 06:30 PM ALLISON R DIRK CEO and Chairman Nov 25 '24 Sale 123.16 12,500 1,539,556 141,897 Nov 26 06:30 PM DIRK ALLISON Officer Nov 25 '24 Proposed Sale 123.17 12,500 1,539,578 Nov 25 04:30 PM Stevenson Roberton James Officer Nov 13 '24 Proposed Sale 130.00 2,250 292,500 Nov 13 06:23 PM POFF BRIAN EVP/Chief Financial Officer Sep 12 '24 Sale 128.62 6,839 879,655 24,705 Sep 13 04:30 PM GAFFNEY SEAN EVP / Chief Legal Officer Sep 12 '24 Sale 129.15 2,962 382,542 15,040 Sep 13 04:30 PM GAFFNEY SEAN Officer Sep 12 '24 Proposed Sale 129.15 2,962 382,542 Sep 12 05:27 PM BRIAN POFF Officer Sep 12 '24 Proposed Sale 128.62 6,839 879,634 Sep 12 04:11 PM Lopez Esteban Director Sep 10 '24 Sale 127.50 500 63,750 3,366 Sep 11 04:30 PM Lopez Esteban Director Sep 04 '24 Sale 130.03 500 65,015 3,866 Sep 06 04:30 PM BICKHAM W BRADLEY President and COO Aug 29 '24 Sale 132.15 3,520 465,168 44,480 Sep 03 04:30 PM BICKHAM W BRADLEY President and COO Aug 30 '24 Sale 132.26 1,480 195,745 43,000 Sep 03 04:30 PM BICKHAM W BRADLEY Officer Aug 29 '24 Proposed Sale 132.00 5,000 660,000 Aug 29 05:08 PM Lopez Esteban Director Aug 29 '24 Proposed Sale 134.00 1,000 134,000 Aug 29 04:08 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Aug 26 '24 Option Exercise 87.80 20,000 1,756,000 29,132 Aug 28 04:30 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Aug 26 '24 Sale 133.29 21,917 2,921,267 7,215 Aug 28 04:30 PM TUCKER DAVID W. EVP / Chief Strategy Officer Aug 26 '24 Option Exercise 85.36 13,133 1,121,079 23,630 Aug 28 04:30 PM TUCKER DAVID W. EVP / Chief Strategy Officer Aug 26 '24 Sale 133.13 15,285 2,034,953 8,345 Aug 28 04:30 PM BLESSING CLIFF DONALD EVP/Chief Development Officer Aug 26 '24 Sale 133.50 1,600 213,592 7,379 Aug 28 04:30 PM TUCKER DAVID W. Officer Aug 26 '24 Proposed Sale 131.00 15,285 2,002,335 Aug 26 05:04 PM BLESSING CLIFF DONALD Officer Aug 26 '24 Proposed Sale 133.00 1,600 212,800 Aug 26 05:02 PM WATTENBARGER MICHAEL D. Officer Aug 26 '24 Proposed Sale 130.00 21,917 2,849,210 Aug 26 04:58 PM Stevenson Roberton James EVP & Chief HR Officer Jun 17 '24 Sale 116.13 217 25,200 10,217 Jun 18 04:05 PM Stevenson Roberton James EVP & Chief HR Officer Apr 01 '24 Sale 103.93 109 11,328 10,434 Apr 02 04:05 PM
Index RUT P/E 26.81 EPS (ttm) 1.23 Insider Own 1.31% Shs Outstand 166.26M Perf Week -4.94%
Market Cap 5.44B Forward P/E 17.75 EPS next Y 1.85 Insider Trans 0.56% Shs Float 163.16M Perf Month 4.91%
Income 211.82M PEG 3.04 EPS next Q 0.34 Inst Own 100.54% Short Float 2.26% Perf Quarter 43.94%
Sales 5.00B P/S 1.09 EPS this Y 1.86% Inst Trans -1.09% Short Ratio 2.02 Perf Half Y 2.24%
Book/sh 8.45 P/B 3.89 EPS next Y 15.13% ROA 6.18% Short Interest 3.68M Perf Year 1.70%
Cash/sh 2.50 P/C 13.18 EPS next 5Y 8.81% ROE 14.99% 52W Range 21.39 - 34.85 Perf YTD 41.77%
Dividend Est. - P/FCF 18.89 EPS past 5Y - ROI 8.17% 52W High -5.62% Beta 1.11
Dividend TTM - Quick Ratio 1.20 Sales past 5Y 16.92% Gross Margin 19.05% 52W Low 53.76% ATR (14) 0.87
Dividend Ex-Date - Current Ratio 1.70 EPS Y/Y TTM -17.16% Oper. Margin 6.44% RSI (14) 56.35 Volatility 2.37% 2.70%
Employees 6015 Debt/Eq 0.87 Sales Y/Y TTM 16.17% Profit Margin 4.24% Recom 1.40 Target Price 38.44
Option/Short Yes / Yes LT Debt/Eq 0.85 EPS Q/Q 9.98% Payout 0.00% Rel Volume 1.44 Prev Close 33.42
Sales Surprise 4.42% EPS Surprise 22.80% Sales Q/Q 19.75% Earnings Feb 26 BMO Avg Volume 1.83M Price 32.89
SMA20 -0.20% SMA50 9.20% SMA200 14.65% Trades
Volume 2,599,999 Change -1.59%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-23-25 Upgrade Jefferies
Hold → Buy
$26 → $35
Jan-13-25 Upgrade BofA Securities
Neutral → Buy
$26 → $33
Dec-05-24 Initiated UBS
Neutral
$26
Nov-04-24 Downgrade Goldman
Buy → Neutral
$27
Oct-31-24 Downgrade Jefferies
Buy → Hold
$38 → $26
Oct-30-24 Downgrade BofA Securities
Buy → Neutral
$43 → $29
Jul-16-24 Initiated JMP Securities
Mkt Outperform
$36
Feb-27-23 Resumed Jefferies
Buy
$38
Jul-19-21 Upgrade Goldman
Neutral → Buy
$20 → $25
Jan-22-21 Initiated Deutsche Bank
Buy
$22
Jan-11-21 Initiated JP Morgan
Overweight
$21
Dec-15-20 Initiated Goldman
Neutral
$18
Jun-24-20 Initiated BofA/Merrill
Buy
$18
Show Previous Ratings
Today 05:04AM
Mar-12-25 05:02AM
Mar-07-25 12:45PM
Mar-06-25 08:03AM
Mar-05-25 08:05AM
08:00AM
Loading…
08:00AM
(Investor's Business Daily)
Mar-04-25 12:20PM
09:15AM
Feb-28-25 09:55AM
Feb-27-25 02:09AM
Feb-26-25 08:17AM
08:05AM
07:11AM
(Associated Press Finance)
07:00AM
Feb-25-25 08:02AM
04:03AM
Loading…
Feb-14-25 04:03AM
04:03AM
04:01AM
Feb-13-25 01:13PM
04:01AM
Feb-11-25 04:03AM
04:02AM
Feb-06-25 11:08AM
Feb-02-25 04:32PM
Jan-29-25 12:10PM
Jan-26-25 03:11AM
Jan-25-25 07:26AM
Jan-14-25 09:58AM
Jan-13-25 10:35AM
07:05AM
04:05PM
Loading…
Dec-04-24 04:05PM
Nov-06-24 04:05PM
Nov-04-24 02:06PM
Oct-31-24 03:07AM
02:57AM
(Thomson Reuters StreetEvents)
Oct-30-24 08:15AM
07:15AM
(Associated Press Finance)
07:00AM
Oct-02-24 04:05PM
Aug-01-24 09:40AM
05:24AM
02:02AM
(Thomson Reuters StreetEvents)
Jul-31-24 08:20AM
07:20AM
(Associated Press Finance)
07:00AM
Jul-22-24 08:28AM
Jul-17-24 05:26PM
Jul-08-24 04:05PM
Jun-28-24 08:03AM
Jun-27-24 02:14PM
02:03PM
Jun-26-24 10:12PM
Jun-03-24 12:00PM
May-16-24 05:23PM
04:05PM
Apr-29-24 04:05PM
Apr-26-24 12:00PM
09:40AM
Apr-25-24 11:27AM
Apr-24-24 03:49AM
(Thomson Reuters StreetEvents)
03:03AM
Apr-23-24 11:54AM
08:33AM
08:19AM
08:15AM
07:15AM
(Associated Press Finance)
07:00AM
Apr-22-24 12:10PM
Apr-16-24 10:00AM
Apr-04-24 04:05PM
Mar-26-24 05:25PM
Mar-14-24 07:14PM
05:04PM
04:58PM
04:25PM
Mar-07-24 10:07AM
Feb-23-24 12:34PM
Feb-22-24 11:53PM
(Thomson Reuters StreetEvents)
08:20AM
07:31AM
07:24AM
(Associated Press Finance)
07:00AM
Feb-02-24 06:10AM
Jan-22-24 04:05PM
Jan-08-24 07:00AM
Dec-19-23 05:14AM
Dec-11-23 04:05PM
Dec-06-23 04:11PM
Nov-07-23 04:05PM
Oct-26-23 09:35AM
Oct-25-23 10:27PM
(Thomson Reuters StreetEvents) -15.49%
07:05PM
09:56AM
08:15AM
07:08AM
(Associated Press Finance)
07:00AM
Oct-20-23 11:47AM
Oct-18-23 12:04PM
Oct-16-23 02:53PM
Oct-02-23 05:56AM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bavaro Michael Chief Human Resources Officer Feb 28 '25 Option Exercise 25.43 14,739 374,784 75,970 Mar 03 05:52 PM Bavaro Michael Chief Human Resources Officer Feb 28 '25 Sale 33.26 30,996 1,030,843 44,974 Mar 03 05:52 PM Bavaro Michael Officer Feb 28 '25 Proposed Sale 33.23 30,996 1,029,900 Feb 28 03:41 PM RADEMACHER JOHN CHARLES Chief Executive Officer Feb 21 '25 Option Exercise 0.00 11,087 0 772,073 Feb 24 08:13 PM SHAPIRO MICHAEL H. Chief Financial Officer Feb 17 '25 Option Exercise 0.00 3,652 0 260,487 Feb 19 06:17 PM KRAEMER HARRY M JANSEN JR Director Nov 08 '24 Buy 22.54 43,000 969,031 326,334 Nov 13 05:27 PM RADEMACHER JOHN CHARLES Chief Executive Officer Oct 26 '24 Option Exercise 0.00 31,216 0 627,615 Oct 29 04:23 PM SHAPIRO MICHAEL H. Chief Financial Officer Oct 21 '24 Option Exercise 0.00 17,088 0 264,405 Oct 23 05:59 PM Pate R Carter Director Sep 03 '24 Sale 32.37 1,465 47,421 36,126 Sep 05 04:21 PM SHAPIRO MICHAEL H. Chief Financial Officer Aug 22 '24 Option Exercise 18.97 23,217 440,426 270,534 Aug 23 05:27 PM SHAPIRO MICHAEL H. Chief Financial Officer Aug 22 '24 Sale 30.95 23,217 718,501 247,317 Aug 23 05:27 PM BETTEN ELIZABETH QUADROS Director Aug 21 '24 Sale 31.09 47,531 1,477,530 21,339 Aug 22 07:38 PM SULLIVAN TIMOTHY P Director Aug 22 '24 Sale 30.91 47,249 1,460,589 20,814 Aug 22 07:36 PM SHAPIRO MICHAEL H. Officer Aug 22 '24 Proposed Sale 32.00 23,217 743,000 Aug 22 12:55 PM SULLIVAN TIMOTHY P Director Aug 22 '24 Proposed Sale 31.00 47,249 1,464,719 Aug 21 05:43 PM BETTEN ELIZABETH QUADROS Director Aug 21 '24 Proposed Sale 32.00 47,531 1,521,000 Aug 21 01:36 PM Bavaro Michael Chief Human Resources Officer Aug 15 '24 Option Exercise 24.93 5,765 143,703 49,193 Aug 19 04:23 PM Bavaro Michael Chief Human Resources Officer Aug 15 '24 Sale 31.42 5,765 181,136 43,428 Aug 19 04:23 PM Bavaro Michael Officer Aug 15 '24 Proposed Sale 32.00 5,765 184,480 Aug 15 12:56 PM Smyser Collin GC & Corporate Secretary May 19 '24 Option Exercise 0.00 812 0 42,120 May 21 04:52 PM
Index RUT P/E 15.76 EPS (ttm) 0.60 Insider Own 35.87% Shs Outstand 134.60M Perf Week -8.72%
Market Cap 1.29B Forward P/E 7.84 EPS next Y 1.22 Insider Trans -0.14% Shs Float 86.49M Perf Month 4.10%
Income 82.57M PEG 1.24 EPS next Q 0.05 Inst Own 73.61% Short Float 10.89% Perf Quarter -2.06%
Sales 3.26B P/S 0.39 EPS this Y -1.43% Inst Trans 8.81% Short Ratio 6.06 Perf Half Y -13.68%
Book/sh 11.67 P/B 0.82 EPS next Y 16.10% ROA 1.80% Short Interest 9.42M Perf Year -12.17%
Cash/sh 0.81 P/C 11.71 EPS next 5Y 12.74% ROE 5.45% 52W Range 8.35 - 11.90 Perf YTD 0.11%
Dividend Est. - P/FCF 5.45 EPS past 5Y - ROI 2.27% 52W High -19.92% Beta 1.51
Dividend TTM - Quick Ratio 1.09 Sales past 5Y 52.49% Gross Margin 15.79% 52W Low 14.13% ATR (14) 0.57
Dividend Ex-Date - Current Ratio 1.33 EPS Y/Y TTM 112.11% Oper. Margin 8.65% RSI (14) 43.46 Volatility 5.60% 5.46%
Employees 10500 Debt/Eq 1.36 Sales Y/Y TTM 1.90% Profit Margin 2.53% Recom 1.78 Target Price 13.00
Option/Short Yes / Yes LT Debt/Eq 1.32 EPS Q/Q 117.60% Payout 0.00% Rel Volume 1.33 Prev Close 10.12
Sales Surprise 3.31% EPS Surprise 51.53% Sales Q/Q -0.19% Earnings Feb 25 BMO Avg Volume 1.56M Price 9.53
SMA20 -3.49% SMA50 -4.69% SMA200 -7.51% Trades
Volume 2,036,285 Change -5.83%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-08-24 Downgrade Jefferies
Buy → Hold
$14.50 → $8
Nov-08-23 Downgrade BofA Securities
Neutral → Underperform
$9.50 → $6.50
May-10-23 Downgrade Stifel
Buy → Hold
$18 → $11
May-10-23 Downgrade Deutsche Bank
Buy → Hold
$28 → $11.30
May-09-23 Downgrade BofA Securities
Buy → Neutral
$21 → $12
Sep-27-21 Initiated SVB Leerink
Outperform
$30
Jul-14-21 Upgrade Robert W. Baird
Neutral → Outperform
$30 → $36
Apr-13-21 Downgrade Robert W. Baird
Outperform → Neutral
Mar-18-21 Initiated Truist
Buy
Jan-26-21 Initiated BofA Securities
Buy
$46
Dec-10-20 Initiated UBS
Buy
$49
Aug-10-20 Initiated Canaccord Genuity
Buy
$31
Jul-01-20 Resumed SVB Leerink
Outperform
$21
Jun-09-20 Initiated RBC Capital Mkts
Outperform
$24
Jan-31-20 Initiated Stifel
Buy
$17
Jan-07-20 Initiated Jefferies
Buy
$15
Dec-11-19 Initiated SVB Leerink
Outperform
Dec-10-19 Initiated Deutsche Bank
Buy
Show Previous Ratings
Mar-12-25 05:02AM
Mar-06-25 04:05PM
Mar-03-25 09:40AM
Feb-27-25 10:10AM
Feb-26-25 08:14AM
02:07AM
Loading…
02:07AM
02:02AM
(Thomson Reuters StreetEvents)
Feb-25-25 01:59PM
08:40AM
07:31AM
07:00AM
01:39AM
Feb-24-25 08:05AM
Feb-17-25 09:35AM
Feb-14-25 04:03AM
04:03AM
Loading…
04:03AM
04:01AM
Feb-13-25 09:40AM
Feb-11-25 04:02AM
Feb-04-25 04:05PM
Jan-28-25 09:40AM
Dec-03-24 08:00AM
Nov-26-24 04:05PM
08:34AM
Nov-12-24 04:05PM
Nov-06-24 02:11AM
Nov-05-24 06:42PM
08:40AM
07:26AM
Oct-24-24 09:40AM
09:40AM
Loading…
09:40AM
Oct-22-24 10:01AM
Oct-17-24 08:00AM
Oct-16-24 08:30AM
Oct-09-24 05:02PM
Oct-08-24 09:40AM
Sep-17-24 03:28PM
(Investor's Business Daily)
Sep-16-24 08:00AM
Aug-27-24 08:30AM
Aug-26-24 07:30AM
Aug-08-24 04:05PM
Aug-06-24 08:30AM
07:00AM
Jul-16-24 08:30AM
Jul-12-24 09:13AM
Jul-02-24 05:21PM
May-22-24 04:39PM
04:36PM
04:33PM
04:30PM
May-20-24 04:05PM
May-14-24 04:45PM
May-08-24 02:57PM
08:00AM
03:19AM
May-07-24 09:48AM
08:43AM
08:36AM
08:10AM
07:00AM
Apr-24-24 09:40AM
Apr-18-24 08:00AM
Apr-17-24 06:51PM
04:15PM
Apr-08-24 09:40AM
Mar-22-24 09:40AM
Mar-08-24 11:59AM
Mar-06-24 09:40AM
Mar-04-24 04:05PM
Mar-01-24 08:00AM
Feb-28-24 10:53AM
Feb-27-24 10:53PM
(Thomson Reuters StreetEvents) +31.06%
11:28AM
07:33AM
07:00AM
Feb-08-24 04:05PM
Dec-19-23 05:05PM
Nov-10-23 08:00AM
Nov-08-23 05:11PM
Nov-07-23 11:41PM
(Thomson Reuters StreetEvents) -8.99%
08:11AM
07:00AM
Oct-17-23 04:05PM
Oct-11-23 12:07PM
Sep-20-23 12:47PM
(Associated Press Finance) -6.49%
11:44AM
08:54AM
08:45AM
08:38AM
Sep-14-23 07:37PM
01:31PM
Sep-07-23 08:00AM
Aug-17-23 07:17PM
07:31AM
Aug-08-23 10:50AM
06:30AM
Aug-03-23 08:00AM
Aug-02-23 01:24PM
Jul-18-23 08:00AM
Jul-17-23 07:27AM
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rietkerk Shaw Officer Dec 19 '24 Proposed Sale 9.70 32,500 315,250 Dec 19 11:02 AM Clemens Jason A Chief Financial Officer Dec 10 '24 Sale 9.35 35,000 327,250 420,719 Dec 12 04:35 PM JASON A CLEMENS &BIANCA S VITA Officer Dec 10 '24 Proposed Sale 9.35 35,000 327,408 Dec 10 04:19 PM Rietkerk Shaw Officer Nov 22 '24 Proposed Sale 9.80 40,000 392,079 Nov 22 04:16 PM WOLF DALE B Director Nov 13 '24 Sale 10.80 7,000 75,600 74,889 Nov 15 04:15 PM WOLF DALE B Director Nov 13 '24 Proposed Sale 10.78 7,000 75,460 Nov 13 12:32 PM Rietkerk Shaw Former Chief Operating Officer Sep 20 '24 Sale 11.24 25,000 281,000 212,611 Sep 24 06:25 PM Rietkerk Shaw Officer Sep 20 '24 Proposed Sale 11.24 25,000 281,040 Sep 20 01:22 PM Richard A. Barasch Former Affiliate Sep 18 '24 Proposed Sale 11.48 40,022 459,452 Sep 18 07:20 PM Richard A. Barasch Former Affiliate Sep 16 '24 Proposed Sale 11.13 14,970 166,616 Sep 16 06:38 PM Richard A. Barasch Former Affiliate Sep 12 '24 Proposed Sale 11.31 10,000 113,100 Sep 12 04:53 PM Richard A. Barasch Former Affiliate Sep 05 '24 Proposed Sale 11.28 13,307 150,103 Sep 05 05:03 PM Williams David Solomon III Director Aug 29 '24 Sale 11.26 4,000 45,040 36,899 Sep 03 08:25 PM Williams David Solomon III Director May 23 '24 Sale 9.90 3,100 30,690 26,679 Sep 03 08:25 PM Williams David Solomon III Director May 24 '24 Sale 9.97 1,409 14,048 25,270 Sep 03 08:25 PM Richard A. Barasch Former Affiliate Aug 28 '24 Proposed Sale 10.79 18,034 194,587 Aug 28 04:17 PM Richard A. Barasch Former Affiliate Aug 19 '24 Proposed Sale 10.46 10,235 107,058 Aug 19 07:08 PM Richard A. Barasch Former Affiliate Aug 15 '24 Proposed Sale 10.04 25,614 257,165 Aug 15 05:00 PM
Index RUT P/E - EPS (ttm) -0.12 Insider Own 61.04% Shs Outstand 174.25M Perf Week -3.43%
Market Cap 3.11B Forward P/E 20.64 EPS next Y 0.86 Insider Trans -0.35% Shs Float 68.17M Perf Month -20.25%
Income -18.06M PEG - EPS next Q 0.11 Inst Own 46.19% Short Float 14.01% Perf Quarter -2.84%
Sales 11.27B P/S 0.28 EPS this Y 11.51% Inst Trans 0.01% Short Ratio 5.76 Perf Half Y 35.99%
Book/sh 9.46 P/B 1.88 EPS next Y 37.77% ROA -0.30% Short Interest 9.55M Perf Year 96.03%
Cash/sh 0.35 P/C 50.74 EPS next 5Y 22.12% ROE -1.62% 52W Range 7.85 - 24.82 Perf YTD 4.29%
Dividend Est. - P/FCF - EPS past 5Y 60.10% ROI -0.41% 52W High -28.44% Beta 2.09
Dividend TTM - Quick Ratio 0.88 Sales past 5Y 20.12% Gross Margin 14.10% 52W Low 126.24% ATR (14) 1.05
Dividend Ex-Date - Current Ratio 1.33 EPS Y/Y TTM 86.89% Oper. Margin 3.05% RSI (14) 39.90 Volatility 8.74% 4.98%
Employees 600 Debt/Eq 1.76 Sales Y/Y TTM 27.65% Profit Margin -0.16% Recom 1.17 Target Price 24.68
Option/Short Yes / Yes LT Debt/Eq 1.68 EPS Q/Q 296.60% Payout - Rel Volume 1.45 Prev Close 16.79
Sales Surprise 1.38% EPS Surprise 3.82% Sales Q/Q 28.56% Earnings Mar 06 BMO Avg Volume 1.66M Price 17.76
SMA20 -7.92% SMA50 -10.73% SMA200 13.56% Trades
Volume 2,370,868 Change 5.78%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-12-24 Initiated CJS Securities
Market Outperform
Oct-11-24 Initiated KeyBanc Capital Markets
Sector Weight
Jun-21-24 Initiated BTIG Research
Buy
$15
Mar-06-24 Initiated HSBC Securities
Buy
$13
Feb-27-24 Upgrade Deutsche Bank
Hold → Buy
$11.50
Feb-20-24 Initiated Wells Fargo
Overweight
$15
Feb-20-24 Initiated UBS
Buy
$15
Feb-20-24 Initiated Morgan Stanley
Overweight
$18
Feb-20-24 Initiated Leerink Partners
Outperform
$15
Feb-20-24 Initiated Jefferies
Buy
$18
Feb-20-24 Initiated Guggenheim
Buy
$15
Feb-20-24 Initiated Goldman
Buy
$26
Feb-20-24 Initiated Deutsche Bank
Hold
$11.50
Feb-20-24 Initiated BofA Securities
Buy
$14
Show Previous Ratings
Mar-12-25 05:02AM
Mar-07-25 02:09AM
01:03AM
(Thomson Reuters StreetEvents)
Mar-06-25 07:10AM
06:05AM
06:00AM
Loading…
06:00AM
Mar-05-25 05:20PM
08:05AM
07:07AM
Feb-22-25 03:59PM
Feb-14-25 03:02PM
01:11PM
Feb-13-25 01:13PM
04:01AM
Feb-11-25 08:30AM
04:03AM
Loading…
04:03AM
Feb-06-25 04:05PM
Feb-02-25 04:31PM
Jan-22-25 05:36AM
02:00AM
01:07AM
(Thomson Reuters StreetEvents)
Jan-21-25 12:52PM
Jan-20-25 06:30PM
Jan-09-25 05:05PM
Jan-07-25 10:50AM
Jan-02-25 12:00PM
Dec-11-24 04:05PM
Nov-26-24 05:00PM
Nov-21-24 04:05PM
Nov-06-24 04:35PM
03:01AM
Loading…
Nov-02-24 03:01AM
Nov-01-24 06:00AM
Oct-31-24 09:04AM
Oct-12-24 05:48PM
Oct-07-24 03:03PM
Oct-01-24 04:05PM
Sep-30-24 07:30AM
Sep-14-24 02:17AM
Sep-13-24 04:00PM
Sep-12-24 11:17AM
Sep-03-24 04:30PM
Aug-26-24 09:00PM
Aug-22-24 04:05PM
Aug-02-24 06:00AM
Jul-08-24 07:30AM
Jul-02-24 04:05PM
Jun-24-24 04:55PM
Jun-06-24 04:35PM
Jun-03-24 07:30AM
May-22-24 04:05PM
07:30AM
May-20-24 07:30AM
May-08-24 09:55AM
May-05-24 08:14AM
May-03-24 03:24AM
May-02-24 10:57AM
06:00AM
Apr-26-24 05:09PM
Apr-10-24 04:35PM
Apr-09-24 04:05PM
Apr-04-24 07:30AM
Mar-26-24 07:30AM
Mar-21-24 07:30AM
Mar-20-24 04:35PM
Mar-14-24 04:45PM
Mar-01-24 08:42AM
Feb-29-24 06:30AM
Feb-15-24 04:35PM
Jan-26-24 04:50PM
04:20PM
(The Wall Street Journal)
04:05PM
BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. Former 10% owner Feb 18 '25 Sale 21.16 12,000,000 253,920,000 11,239,996 Feb 20 04:30 PM Walgreen Co. 10% Owner Feb 18 '25 Proposed Sale 22.15 12,000,000 265,800,000 Feb 18 09:07 PM Walgreens Boots Alliance, Inc. 10% Owner Sep 11 '24 Sale 11.13 11,619,998 129,330,578 23,239,996 Sep 13 07:04 PM KKR Group Partnership L.P. 10% Owner Sep 11 '24 Buy 11.13 11,619,998 129,330,578 92,959,984 Sep 13 04:44 PM KKR Phoenix Aggregator L.P. 10% Owner Sep 11 '24 Buy 11.13 11,619,998 129,330,578 92,959,984 Sep 13 04:36 PM DAmbrosio Matthew Director May 20 '24 Buy 11.46 1,000 11,461 1,000 May 21 06:17 PM Yowler Jennifer President, PharMerica Mar 15 '24 Buy 8.21 3,000 24,630 60,880 Mar 18 03:27 PM Mattingly James F Jr See Remarks Mar 15 '24 Buy 8.26 6,080 50,221 134,780 Mar 18 03:27 PM ROUSSEAU JON B See Remarks Mar 15 '24 Buy 8.09 18,400 148,856 369,763 Mar 18 03:26 PM ROUSSEAU JON B See Remarks Mar 15 '24 Buy 8.09 18,400 148,856 1,025,636 Mar 18 03:26 PM Phipps Jennifer A Chief Accounting Officer Mar 14 '24 Buy 8.14 12,300 100,122 165,618 Mar 15 05:34 PM Mattingly James F Jr See Remarks Mar 14 '24 Buy 8.18 12,280 100,450 128,700 Mar 15 05:34 PM ROUSSEAU JON B See Remarks Mar 14 '24 Buy 8.12 37,405 303,729 39,352 Mar 15 05:33 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
